Clin2
NCT06712602Possibly a fitRecruiting

Testing PT150 for Alcohol Use Disorder

Alcohol Use Disorder

Treatments studied

Part of Mental health clinical trials.

This study tests whether a drug called PT150 can help people with moderate to severe alcohol use disorder who are not currently seeking treatment. You will be asked to stay abstinent from alcohol for short periods and attend sessions to see how PT150 affects your body and alcohol cravings.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
34 people
Ages
21 years to 55 years
Study type
Interventional

Who can take part

  • You must have moderate to severe alcohol use disorder as diagnosed by a doctor.
  • You are not currently trying to quit or get treatment for your drinking.
  • You are between 21 and 55 years old.
  • You are generally healthy aside from your alcohol use (and possibly tobacco use).
  • You can stay away from alcohol for at least 12 hours before study sessions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05778734Recruiting
Study to help young adults improve alcohol steadiness

This study is looking at ways to increase “alcohol abstinence,” meaning drinking less or stopping. It focuses on young adults who currently drink and have symptoms of alcohol use disorder, and it may help them build skills to reduce or stop drinking.

Chicago, Illinois
NCT05957159Recruiting· Early Phase 1
Testing an alcohol brain imaging study based on opioid receptor balance

This early-phase study looks at how the brain’s opioid receptor balance may be different in people with alcohol use disorder (AUD), using brain scans and blood testing. It may help researchers understand why some people respond differently to alcohol and related treatments.

New Haven, Connecticut
NCT06489782Recruiting
New approach to test alcohol use disorder medications

This study tests a new way to quickly screen medications for alcohol use disorder (AUD). You will have lab sessions where your drinking is monitored to see how different medicines affect your alcohol use.

New Haven, Connecticut
NCT03827460Recruiting· Phase 1
Study tests how men and women respond to alcohol abstinence

This Phase 1 study looks at sex differences in how the body and brain respond when people stop drinking alcohol for a short time. You may be asked to complete questionnaires and provide blood samples to measure changes during the abstinence period.

Indianapolis, Indiana
NCT06269627Recruiting· Phase 4
Brain activity study for alcohol use treatment

This trial tests how the medication acamprosate affects brain activity in people with moderate to severe alcohol use disorder. It may help researchers understand how this treatment works.

Bethesda, Maryland
NCT06349083Recruiting· Phase 2
Psilocybin-assisted treatment for alcohol use disorder

This study tests whether psilocybin, a psychedelic drug, combined with therapy can help people reduce or stop drinking. It aims to understand how psilocybin affects the brain and behavior in people with alcohol use disorder.

New York, New York

Hear when a new Alcohol Use Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.